Distinguished in Nevoid Basal Cell Carcinoma Syndrome

Klara Mosterd

Maastricht, LI, NL 
Distinguished in Nevoid Basal Cell Carcinoma Syndrome
Maastricht, LI, NL 
OverviewLocationsClinical Research

Overview

Klara Mosterd practices in Maastricht, Netherlands. Ms. Mosterd is rated as a Distinguished expert by MediFind in the treatment of Nevoid Basal Cell Carcinoma Syndrome. Her top areas of expertise are Basal Cell Skin Cancer, Nevoid Basal Cell Carcinoma Syndrome, Bowen's Disease, and Actinic Keratosis.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles and participated in 1 clinical trial in the study of Nevoid Basal Cell Carcinoma Syndrome.

Gender
Female

Locations

Maastricht, LI, Netherlands
Other Locations
Venlo, LI, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease: a Multicenter Randomized Controlled Trial
Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease: a Multicenter Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Drug, Other
Study Drugs: Methyl Aminolevulinate, 5Fluorouracil
Study Phase: Phase 4
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Phase: Phase 3
Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial
Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial
Enrollment Status: Unknown
Publish Date: September 24, 2021
Intervention Type: Procedure, Drug
Study Drug: Imiquimod
Study Phase: Phase 3
View 2 Less Clinical Trials

109 Total Publications

Cost-effectiveness of Photodynamic Therapy and 5-Fluorouracil Cream versus Surgical Excision in Treatment of Bowen's Disease: a trial based economic evaluation.
Cost-effectiveness of Photodynamic Therapy and 5-Fluorouracil Cream versus Surgical Excision in Treatment of Bowen's Disease: a trial based economic evaluation.
Journal: Dermatology (Basel, Switzerland)
Published: May 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mosterd's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile